61
Views
31
CrossRef citations to date
0
Altmetric
Original Article

Impaired insulin action on granulosa-lutein cells in women with polycystic ovary syndrome and insulin resistance

, , , &
Pages 327-336 | Published online: 05 Aug 2009

References

  • Franks S. Polycystic ovary syndrome. N Engl J Med 1995; 333: 853–61
  • Poretsky L, Piper B. Insulin resistance, hypersecretion of LH, and a dual-defect hypothesis for the pathogenesis of polycystic ovary syndrome. Obstet Gynecol 1994; 84: 613–21
  • Dale PO, Tanbo T, Vaaler S, et al. Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations. Fertil Steril 1992; 58: 487–91
  • Prelevic GM, Wurzburger MI, Balint-Peric L, et al. Inhibitory effect of sandostatin on secretion on luteinising hormone and ovarian steroids in polycystic ovary syndrome. Lancet 1990; 336: 900–3
  • Rajkhowa M, Bicknell J, Jones M, et al. Insulin sensitivity in women with polycystic ovary syndrome: relationship to hyperandrogenemia. Fertil Steril 1994; 61: 605–12
  • Sharp PS, Kiddy D, Reed MJ, et al. Correlation of plasma insulin and insulin-like growth factor-I with indices of androgen transport and metabolism in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 1991; 35: 253–7
  • Nahum R, Thong KJ, Hillier SG. Metabolic regulation of androgen production by human thecal cells in vitro. Hum Reprod 1995; 10: 75–81
  • Willis D, Franks S. Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor. J Clin Endocrinol Metab 1995; 80: 3788–90
  • Poretsky L. On the paradox of insulin-induced hyperandrogenism in insulin-resistant states. Endocrinol Rev 1991; 12: 3–13
  • Poretsky L, Grigorescu F, Seibel M, et al. Distribution and characterization of insulin and insulin-like growth factor I receptors in normal human ovary. J Clin Endocrinol Metab 1985; 61: 728–34
  • Veldhuis JD, Kolp LA, Toaff ME, et al. Mechanisms subserving the trophic actions of insulin on ovarian cells. In vitro studies using swine granulosa cells. J Clin Invest 1983; 72: 1046–57
  • Veldhuis JD, Nestler JE, Strauss JF, III, et al. Insulin regulates low density lipoprotein metabolism by swine granulosa cells. Endocrinology 1986; 118: 2242–53
  • Andreani CL, Pierro E, Lanzone A, et al. Effect of gonadotropins, insulin and IGF-I on granulosa luteal cells from polycystic ovaries. Mol Cell Endocrinol 1994; 106: 91–7
  • Willis D, Mason H, Gilling-Smith C, et al. Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab 1996; 81: 302–9
  • Hoist N, Kierulf KH, Seppala M, et al. Regulation of insulin-like growth factor-binding protein-1 and progesterone secretion from human granulosaluteal cells: effects of octreotide and insulin. Fertil Steril 1997; 68: 478–82
  • Ciaraldi TP, el-Roeiy A, Madar Z, et al. Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab 1992; 75: 577–83
  • Dunaif A, Xia J, Book CB, et al. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest 1995; 96: 801–10
  • Dunaif A. Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus. Am J Med 1995; 98: 33S–39S
  • Adams J, Franks S, Poison DW, et al. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet 1985; 2: 1375–9
  • Hosker JP, Matthews DR, Rudenski AS, et al. Continuous infusion of glucose with model assessment: measurements of insulin resistance and beta-cell function in man. Diabetologia 1985; 28: 401–11
  • Dale PO, Tanbo T, Haug E, et al. Polycystic ovary syndrome: low-dose follicle stimulating hormone administration is a safe stimulation regimen even in previous hyper-responsive patients. Hum Reprod 1992; 7: 1085–9
  • Torjesen P, Sand T, Norman N, et al. Isolation of LH, FSH and TSH from human pituitaries after removal of HGH. Acta Endocrinol 1974; 77: 485–97
  • Soto E, Silavin SL, Tureck RW, et al. Stimulation of progesterone synthesis in luteinized human granulosa cells by human chorionic gonadotropin and 8-bromo-adenosine 3′,5′-monophosphate: the effect of low density lipoprotein. J Clin Endocrinol Metab 1984; 58: 831–7
  • Richardson MC, Davies DW, Watson RH, et al. Cultured human granulosa cells as a model for corpus luteum function: relative roles of gonadotrophin and low density lipoprotein studied under defined culture conditions. Hum Reprod 1992; 7: 12–8
  • Sorensen K, Brodbeck U. A sensitive protein assay methods using micro-titer plates. Experientia 1986; 52: 161–2
  • Tanbo T, Dale PO, Kjekshus E, et al. Stimulation with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression in polycystic ovarian syndrome. Fertil Steril 1990; 53: 798–803
  • Tanbo T, Åbyholm T, Magnus O, et al. Gonadotropin and ovarian steroid production in polycystic ovarian syndrome during suppression with gonadotropin-releasing hormone agonist. Gynecol Obstet Invest 1989; 28: 147–51
  • Harlow CR, Winston RM, Margara RA, et al. Gonadotrophic control of human granulosa cell glycolysis. Hum Reprod 1987; 2: 649–53
  • Lin Y, Fridstrom M, Hillensjo T. Insulin stimulation of lactate accumulation in isolated human granulosa-luteal cells: a comparison between normal and polycystic ovaries. Hum Reprod 1997; 12: 2469–72
  • Samoto T, Maruo T, Matsuo H, et al. Altered expression of insulin and insulin-like growth factor-I receptors in follicular and stromal compartments of polycystic ovaries. Endocr J 1993; 40: 413–24
  • Dale PO, Tanbo T, Haug E, et al. The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome. Hum Reprod 1998; 13: 567–70
  • Fulghesu AM, Villa P, Pavone V, et al. The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome. J Clin Endocrinol Metab 1997; 82: 644–8
  • Donderwinkel PF, Schoot DC, Pache TD, et al. Luteal function following ovulation induction in polycystic ovary syndrome patients using exogenous gonadotrophins in combination with a gonadotrophin-releasing hormone agonist. Hum Reprod 1993; 8: 2027–32
  • Hamori M, Torok A, Zwirner M, et al. Hum Reprod 1992; 7: 592–6, In-vitro progesterone production of human granulosa-luteal cells: the impact of different stimulation protocols, poor ovarian response and polycystic ovarian syndrome.
  • Abdel Gadir A, Mowafi RS, Alnaser HM, et al. Ovarian electrocautery versus human menopausal gonadotrophins and pure follicle stimulating hormone therapy in the treatment of patients with ovarian disease. Clin Endocrinol (Oxf) 1990; 33: 585–92
  • Hill GA, Osteen KG. The effect of insulin on in vitro progesterone production of human granulosa cells. Int J Fertil 1992; 37: 93–8
  • Volpe A, Coukos G, Uccelli E, et al. Follicular fluid lipoproteins in preovulatory period and their relationship with follicular maturation and progesterone production by human granulosaluteal cells in vivo and in vitro. J Endocrinol Invest 1991; 14: 737–42

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.